Ligand Pharmaceuticals Inc (LGND)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Ligand Pharmaceuticals Inc Stock (LGND) Financials Data

*All numbers in millions

Period End Date	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Period Length	3 Months	3 Months	3 Months	3 Months	3 Months
Revenues	10.24% 30.98	28.10	32.87	26.37	43.98
Operating Expenses	11.03% 27.99	31.46	29.79	28.35	29.77
Interest Income/Expense	7.63% 0.141	0.131	0.001	0.284	0.24
Benefits Costs and Expenses	849.45% -82.47	11.00	45.01	23.20	-11.56
Costs And Expenses	849.45% -82.47	11.00	45.01	23.20	-11.56
Operating Income/Loss	188.98% 2.988	-3.358	3.078	-1.983	14.21
Nonoperating Income/Loss	440.01% 110.46	20.45	-15.22	5.154	41.33
Income/Loss Before Equity Method Investments	115.80	-	-	-	-
Income/Loss From Equity Method Investments	-2.352	-	-	-	-
Income/Loss From Continuing Operations Before Tax	563.55% 113.45	17.10	-12.14	3.171	55.54
Income Tax Expense/Benefit	2,603% 27.31	-1.091	-1.871	0.881	11.92
Income/Loss From Continuing Operations After Tax	373.60% 86.14	18.19	-10.27	2.29	43.61
Income/Loss From Discontinued Operations, Net Of Tax	-	-	-	-	-1.665
Net Income/Loss	373.60% 86.14	18.19	-10.27	2.29	41.95
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	31,009% 17.73	0.057	17.38	17.28	17.06
Diluted Average Shares	67,219% 18.12	-0.027	17.38	17.73	17.97
Basic Earnings Per Share	362.86% 4.86	1.05	-0.59	0.13	2.46
Diluted Earnings Per Share	361.17% 4.75	1.03	-0.59	0.13	2.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INSM

$80.78

0.82%

SMMT

$20.67

0.53%

UTHR

$353.75

0.12%

NEUP

$5.04

2.14%

ONC

$228.87

0.53%

BNTX

$119.94

1.99%